Brokerages Set Transcat, Inc. (NASDAQ:TRNS) PT at $105.33

Shares of Transcat, Inc. (NASDAQ:TRNS) have earned a consensus rating of “Buy” from the five brokerages that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a buy rating and two have given a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $105.3333.

Several brokerages have recently commented on TRNS. Zacks Research upgraded Transcat from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 7th. Northland Securities set a $95.00 target price on Transcat in a research report on Thursday, October 23rd. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th.

Institutional Trading of Transcat

A number of institutional investors have recently bought and sold shares of TRNS. Conestoga Capital Advisors LLC increased its position in shares of Transcat by 13.7% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 1,088,471 shares of the scientific and technical instruments company’s stock valued at $93,565,000 after acquiring an additional 131,217 shares during the period. Bessemer Group Inc. increased its holdings in shares of Transcat by 35.8% in the second quarter. Bessemer Group Inc. now owns 244,491 shares of the scientific and technical instruments company’s stock valued at $21,016,000 after purchasing an additional 64,422 shares during the period. Sei Investments Co. raised its stake in shares of Transcat by 627.4% in the second quarter. Sei Investments Co. now owns 47,203 shares of the scientific and technical instruments company’s stock worth $4,058,000 after purchasing an additional 40,714 shares during the last quarter. 4D Advisors LLC acquired a new stake in shares of Transcat during the second quarter worth about $3,009,000. Finally, Teachers Retirement System of The State of Kentucky acquired a new stake in shares of Transcat during the fourth quarter worth about $1,974,000. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Stock Up 3.1%

NASDAQ:TRNS opened at $60.31 on Monday. The company’s 50-day simple moving average is $58.90 and its 200-day simple moving average is $68.90. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.06 and a current ratio of 2.43. Transcat has a fifty-two week low of $50.23 and a fifty-two week high of $97.08. The stock has a market capitalization of $562.69 million, a P/E ratio of 49.43 and a beta of 0.78.

Transcat (NASDAQ:TRNS) last posted its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.02). The firm had revenue of $82.27 million for the quarter, compared to analysts’ expectations of $79.51 million. Transcat had a net margin of 3.75% and a return on equity of 6.81%. On average, equities analysts anticipate that Transcat will post 2.3 earnings per share for the current fiscal year.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.